|
|
 |
|
Viewing report
|
|
|
|
Dr Reddy's Laboratories Generics Company Intelligence Report
Espicom Business Intelligence Ltd, March 2009, Pages: 20
EXECUTIVE SUMMARY
INTRODUCTION
Dr Reddy's launches US Specialty Business
Dr Reddy’s realigns Global Generics geography portfolio
PRODUCTS
Dr Reddy’s files fondaparinux ANDA for Alchemia
Dr Reddy’s ANDA Approvals, 2002-09
Recent product approvals
Divalproex
Dr Reddy’s announces ANDA approvals
Lamotrigine
Sumatriptan (US authorised generic)
Dr Reddy’s enters Indian inhalers market
Venlafaxine
Atorvastatin+ramipril
FINANCIAL RESULTS
Latest Quarterly Results, Q309
Global Generics
Dr Reddy’s: Third Quarter Results, in Rs millions
Dr Reddy’s: Third Quarter Results, in US$ millions
Dr Reddy’s crosses US$150 million revenue milestone in Russia and CIS
Latest fiscal year results, FY2008
Dr Reddy’s: Full Year Results, Fiscal year to 31st March in Rs millions
Dr Reddy’s: Full Year Results, Fiscal year to 31st March in US$ millions
Segment Data
Branded Formulations
Active Pharmaceutical Ingredients and Intermediates
Dr Reddy’s: Revenues from Key API Products Across all Regions, in Rs millions
Dr Reddy’s: Revenues from Key API Products Across all Regions, in US$ millions
Generics
Custom Pharmaceutical Services (CPS)
Dr Reddy’s: Full Year Results by Segments, Fiscal year to 31st March in Rs millions
Dr Reddy’s: Full Year Results by Segments, Fiscal year to 31st March in US$ millions
MAJOR DEVELOPMENTS
Dr Reddy's, Stada and Teva report successes in AOK tenders in the German market
Mergers, acquisitions & agreements
Dr Reddy’s makes dermatology product advances
TMH/Dr Reddy's sign agreement to create self-injectable product
Dr Reddy's and Albemarle sign ibuprofen API deal
Aquapharm signs new agreement and extends R&D licence with Dr Reddy's
Dr Reddy's to buy BASF contract manufacturing operations
Dowpharma's UK Small Molecules business sold to Dr Reddy's
Dr Reddy’s acquires Jet Generici
7TM/Dr Reddy's enter drug-discovery collaboration
Dr Reddy's/SkyePharma collaborate on feasibility study
Litigation
Dr Reddy’s gains favourable omeprazole ruling
Dr Reddy's enter desloratadine litigation settlement
Teva and Dr Reddy’s settle carvedilol suit
AstraZeneca sues Dr Reddy’s over generic zafirlukast
US court affirms that Eisai's Aciphex patent is valid and enforceable
Dr Reddy's and Novartis settle rivastigmine litigation
Forest and Merz file additional lawsuit for Namenda patent infringement
CONTACT DETAILS
Customers who bought this item also bought
Reddy Ice Holdings, Inc.
D.R. Horton, Inc. - SWOT Analysis
The Indian Pharmaceutical Industry: Expansion & Ambitions
Q3 2005 Earnings Call - Dr. Reddy's Laboratories Ltd. - Earnings Transcript
Q3 2005 Earnings Call - Dr. Reddy's Laboratories Ltd. - Earnings Transcript
Q4 2005 Earnings Call - Dr. Reddy's Laboratories Ltd. - Earnings Transcript
The Indian Pharmaceutical Industry: Expansion & Ambitions + Indian Pharma Industry Tracker
BC/DR Implementations and Demand for BC/DR Consulting Services Among US Businesses
The Indian Pharmaceutical Industry 2009: Diversification, Expansion & Ambitions
DR REDDY'S LABORATORIES - World'Vest Base Dossier
Teva Pharmaceutical Industries Generics Company Intelligence Report
D.R. Horton, Inc
|
|
|
|
